not tagged
cel-sci
['head and neck', 'cel-sci']
 cel-sci's phase 3 data presented at esmo paris 2022: neoadjuvant multikine achieved groundbreaking tumor response &amp; extended overall survival in locally advanced head and neck cancer - 5 minutes ago.